Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agree James. What I also can't get my arms around is why they would consider scrapping a Phase III trial in progress that has an FDA SPA already granted and why no one would want to partner with it. We're also talking about a construct (HPV cervical) that showed best ever survival in its Phase II trial (better than Avastin). And the current Phase III trial is doubled blinded I believe so its not as if they looked at the data and didn't think it was going well (they don't know). Perhaps given the rapid progress in immunotherapy folks see our fist gen constructs as dated now. Goes to show how fatal and shortsighted O'Connor's business strategy was not partnering AXAL early to instead hold out and try to get more later. Meanwhile Issaacs partnered ADRO's first gen constructs early in deals valued at $1.2 billion to J&N, smart move, as ADRO's market value is now over $600 million while ours is less than $100 million yet our tech is supposedly superior. IMO O'Connor should be in jail for what he did to investors and be required to pay back the unearned comp he took from shareholder capital.